OptimizeRx Corporation
OPRX
$17.00
-$0.25-1.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.91% | 14.71% | -14.48% | -75.81% | -24.83% |
| Total Depreciation and Amortization | 24.82% | 48.62% | 82.86% | 116.34% | 102.72% |
| Total Amortization of Deferred Charges | 77.49% | 103.61% | 295.73% | 860.54% | 554.74% |
| Total Other Non-Cash Items | -24.58% | -20.56% | -18.31% | 62.59% | 24.62% |
| Change in Net Operating Assets | 86.03% | 94.27% | 104.32% | -266.79% | -1,289.72% |
| Cash from Operations | 652.47% | 231.75% | 167.53% | -186.03% | -149.47% |
| Capital Expenditure | 37.39% | -18.89% | -28.74% | -1.73% | -29.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.50% | -100.48% | -100.61% | 405.64% | 198.22% |
| Cash from Investing | 98.75% | 98.41% | 98.22% | -47.76% | 49.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -195.20% | -81.00% | -133.92% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -91.15% | -95.88% |
| Repurchase of Common Stock | 40.27% | 89.18% | 88.56% | 95.20% | 97.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | -124.64% | -117.53% | -117.40% | 321.32% | 226.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -200.00% | -- |
| Net Change in Cash | -68.44% | 210.36% | 89.17% | 119.75% | 106.64% |